Dorin Schumacher

with offices in West Lafayette, Ind. Dorin Schumacher, president of The Consortium for Plant Biotechnology Research Inc. (CPBR), views her organization as a unique model that fosters interaction among university, industry, and federal laboratories. Founded in Illinois in 1985, the consortium, which has members from across the United States, seeks to strengthen the nation's competitive position in the global biotechnology market by

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Dorin Schumacher, president of The Consortium for Plant Biotechnology Research Inc. (CPBR), views her organization as a unique model that fosters interaction among university, industry, and federal laboratories. Founded in Illinois in 1985, the consortium, which has members from across the United States, seeks to strengthen the nation's competitive position in the global biotechnology market by promoting cooperative research and development efforts among the three sectors.

Schumacher believes that academe stands to profit from working relationships with business by keeping abreast of "real world" situations, and gaining support for teaching and research. Concurrently, business benefits from academe in employee recruitment, education, and retraining, as well as research assistance leading to fundamental discoveries--and applying those discoveries to current problems. In using the expertise and facilities of federal laboratories, academe and busines can also take advantage of developing technologies.

Schumacher attributes the success of CPBR to its rigorous, highly competitive project selection ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies